Literature DB >> 1648607

Internalization and processing of basic fibroblast growth factor by neurons and astrocytes.

P A Walicke1, A Baird.   

Abstract

The fate of iodinated basic fibroblast growth factor (FGF) after its binding to cultured astrocytes and hippocampal neurons was studied. Autoradiography after light and electron microscopy establishes that, if cells are returned to 37 degrees C, the 125I-basic FGF bound internalizes into vesicles in the cytoplasm, localizes to the perinuclear cytoplasm, and is translocated to chromatin structures of the nucleus. The radiolabeled protein is long-lived, a finding confirmed by biochemical analyses. Polyacrylamide gel electrophoresis and autoradiography of both hippocampal neurons and astrocyte extracts reveal that these cells internalize 125I-basic FGF and then metabolize it to three major heparin-binding peptides with molecular weights of 15.5, 9, and 4 kDa. These peptides are initially detected 16 hr after binding to neurons and 4 hr after binding to astrocytes but are still detectable 48 and 16 hr, respectively, after initial binding (though present at lower levels). Immunoprecipitation with sequence-specific antisera to basic FGF reveals that the 15.5-kDa fragment is generated by cleavage at the carboxyl terminus, that the 9-kDa peptide contains the sequences between residues 30 and 87, and the 4-kDa peptide is a C-terminus fragment containing the sequence of basic FGF(106-120) but without basic FGF(139-146) immunoreactivity. The internalization of basic FGF is required for this processing; the treatment of cells with trypsin and 2 M NaCl at different times after binding can only prevent the metabolism of basic FGF if it is performed immediately after binding. Similarly, WGA, which inhibits basic FGF binding to its high-affinity receptor, prevents the metabolism of basic FGF. The possible significance of a metabolic pathway that is responsible for the processing of basic FGF after its internalization by cells in the CNS is discussed in light of its potential function as a neurotrophic factor.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1648607      PMCID: PMC6575483     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  13 in total

1.  A femtomolar-acting neuroprotective peptide.

Authors:  D E Brenneman; I Gozes
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

2.  Changes in the properties of gap junctions during neuronal differentiation of hippocampal progenitor cells.

Authors:  R Rozental; M Morales; M F Mehler; M Urban; M Kremer; R Dermietzel; J A Kessler; D C Spray
Journal:  J Neurosci       Date:  1998-03-01       Impact factor: 6.167

3.  Cell-surface ADP-ribosylation of fibroblast growth factor-2 by an arginine-specific ADP-ribosyltransferase.

Authors:  E M Jones; A Baird
Journal:  Biochem J       Date:  1997-04-01       Impact factor: 3.857

4.  A 10-amino acid sequence of fibroblast growth factor 2 is sufficient for its mitogenic activity on neural progenitor cells.

Authors:  J Ray; A Baird; F H Gage
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

Review 5.  Activity-dependent neurotrophic factor (ADNF). An extracellular neuroprotective chaperonin?

Authors:  I Gozes; D E Brenneman
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

6.  Immunohistochemical expression of basic fibroblast growth factor and fibroblast growth factor receptors 1 and 2 in the pathogenesis of lung cancer.

Authors:  Carmen Behrens; Heather Y Lin; J Jack Lee; Maria Gabriela Raso; Waun Ki Hong; Ignacio I Wistuba; Reuben Lotan
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

7.  Interaction of FGF-2 with IGF-1 and BDNF in stimulating Akt, ERK, and neuronal survival in hippocampal cultures.

Authors:  Nadine N Johnson-Farley; Khushboo Patel; Deborah Kim; Daniel S Cowen
Journal:  Brain Res       Date:  2007-04-19       Impact factor: 3.252

8.  Proliferation, differentiation, and long-term culture of primary hippocampal neurons.

Authors:  J Ray; D A Peterson; M Schinstine; F H Gage
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

9.  Increased basic fibroblast growth factor immunoreactivity in the brain of stroke-prone spontaneously hypertensive rats.

Authors:  H Kataoka; E Yamada; F Hazama
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

10.  Herpes simplex virus infection can occur without involvement of the fibroblast growth factor receptor.

Authors:  M I Muggeridge; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.